Compare GH & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GH | STE |
|---|---|---|
| Founded | 2011 | 1985 |
| Country | United States | United States |
| Employees | N/A | 3700 |
| Industry | Medical Specialities | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.9B | 21.3B |
| IPO Year | 2018 | 2018 |
| Metric | GH | STE |
|---|---|---|
| Price | $158.26 | $222.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 26 | 9 |
| Target Price | $201.64 | ★ $262.14 |
| AVG Volume (30 Days) | ★ 1.8M | 594.2K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 1.23% |
| EPS Growth | 6.74 | ★ 27.90 |
| EPS | N/A | ★ 7.93 |
| Revenue | $982,021,000.00 | ★ $5,935,900,000.00 |
| Revenue This Year | $38.42 | $7.35 |
| Revenue Next Year | $35.13 | $6.36 |
| P/E Ratio | ★ N/A | $28.21 |
| Revenue Growth | ★ 32.88 | 8.73 |
| 52 Week Low | $65.96 | $195.14 |
| 52 Week High | $191.05 | $269.44 |
| Indicator | GH | STE |
|---|---|---|
| Relative Strength Index (RSI) | 38.93 | 60.32 |
| Support Level | $153.88 | $216.22 |
| Resistance Level | $173.94 | $227.10 |
| Average True Range (ATR) | 8.16 | 4.32 |
| MACD | -2.16 | 2.08 |
| Stochastic Oscillator | 1.83 | 75.07 |
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.